Patients will be treated with the fractionation of 30 Gy in 5 fractions over 1-2 weeks, which is the accelerated fractionation scheme of choice for Radiation Therapy (RT) naïve patients at New York Presbyterian using EBRT or with the fractionation of 4050 cGy in 15 fractions over 3 weeks, based on the previous treatment that they received.
The main aim of the study is to evaluate the rate of early grade 3 toxicities with this approach.
Age
19–90
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Isolated ipsilateral unifocal breast lesions
Limited size (\< 2-3 cm) without evidence of skin involvement
Histologically proven invasive breast carcinoma or carcinoma in situ
Negative histologic margins of resection
Patients with 0 to 3 positive axillary lymph nodes without extracapsular extension
No synchronous distant metastases
Age ≥ 18 years
≥ 12 months interval between initial breast conserving therapy (surgery and whole breast radiotherapy) and recurrence
Previous WBI or IORT, brachytherapy or external beam partial breast treatment
Technical feasibility
Every kind of systemic therapy is allowed
Informed consent for clinical and research purposes signed